Life Sciences firm Danaher on Tuesday beat Wall Street's third-quarter profit and revenue estimates, buoyed by resilient demand for its diagnostic testing tools and services, sending its shares up 1.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback